HU195802B - Process for production of 1-cycloprophil-6-fluor-7-/pirrol-1-il/-1,4-dihydro-3-carboxi-4-oxo-quinoline and medical compositions containing them - Google Patents

Process for production of 1-cycloprophil-6-fluor-7-/pirrol-1-il/-1,4-dihydro-3-carboxi-4-oxo-quinoline and medical compositions containing them Download PDF

Info

Publication number
HU195802B
HU195802B HU854757A HU475785A HU195802B HU 195802 B HU195802 B HU 195802B HU 854757 A HU854757 A HU 854757A HU 475785 A HU475785 A HU 475785A HU 195802 B HU195802 B HU 195802B
Authority
HU
Hungary
Prior art keywords
oxo
atcc
dihydro
pyrrol
quinoline
Prior art date
Application number
HU854757A
Other languages
English (en)
Hungarian (hu)
Other versions
HUT40640A (en
Inventor
Soler Jose Esteve
Original Assignee
Provesan Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Provesan Sa filed Critical Provesan Sa
Publication of HUT40640A publication Critical patent/HUT40640A/hu
Publication of HU195802B publication Critical patent/HU195802B/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • C07D207/327—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HU854757A 1984-12-12 1985-12-12 Process for production of 1-cycloprophil-6-fluor-7-/pirrol-1-il/-1,4-dihydro-3-carboxi-4-oxo-quinoline and medical compositions containing them HU195802B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8419001A FR2574404B1 (fr) 1984-12-12 1984-12-12 Derives 1-substitues de l'acide 6-fluoro-7-(pyrrol-1-yl)-1,4-dihydro-4-oxoquinoleine-3-carboxylique, leur preparation et leur application en tant que medicaments

Publications (2)

Publication Number Publication Date
HUT40640A HUT40640A (en) 1987-01-28
HU195802B true HU195802B (en) 1988-07-28

Family

ID=9310528

Family Applications (1)

Application Number Title Priority Date Filing Date
HU854757A HU195802B (en) 1984-12-12 1985-12-12 Process for production of 1-cycloprophil-6-fluor-7-/pirrol-1-il/-1,4-dihydro-3-carboxi-4-oxo-quinoline and medical compositions containing them

Country Status (15)

Country Link
US (1) US4727080A (en, 2012)
EP (1) EP0187085B1 (en, 2012)
JP (1) JPS61197577A (en, 2012)
AT (1) ATE56446T1 (en, 2012)
CS (1) CS258136B2 (en, 2012)
DD (1) DD242042A5 (en, 2012)
DE (1) DE3579683D1 (en, 2012)
ES (1) ES8704930A1 (en, 2012)
FR (1) FR2574404B1 (en, 2012)
HU (1) HU195802B (en, 2012)
PL (1) PL146541B1 (en, 2012)
PT (1) PT81652B (en, 2012)
RO (1) RO93482B (en, 2012)
SU (1) SU1426453A3 (en, 2012)
YU (1) YU43691B (en, 2012)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3519286A1 (de) * 1985-05-30 1986-12-04 Bayer Ag, 5090 Leverkusen 7-azolyl-1-cyclopropyl-1,4-dihydro-4-oxo-3- chinolincarbonsaeuren und -1,8-naphthyridin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3606698A1 (de) * 1986-03-01 1987-09-03 Bayer Ag 7-(1-pyrrolidinyl)-chinoloncarbonsaeure -derivate
US5153204A (en) * 1986-03-01 1992-10-06 Bayer Aktiengesellschaft 7-(1-Pyrrolidinyl)-quinolonecarboxylic acid derivatives
DE3639465A1 (de) * 1986-11-18 1988-05-19 Hoechst Ag Optisch aktive gyrasehemmer, ihre herstellung und verwendung als antibiotika
FR2629456B1 (fr) * 1988-03-31 1991-07-05 Esteve Labor Dr Derives des acides 7-(1-imidazolyl),1,4-dihydro-4-oxo-6,8-difluoro-1-cyclopropyl-3-quinoleincarboxylique, leur preparation et leur application en tant que medicaments
US5103040A (en) * 1988-06-21 1992-04-07 Pfizer Inc. 6-fluoro-1,4-dihydroquinol-4-one-3-carboxylic acid derivatives and intermediates therefor
US5039682A (en) * 1988-06-21 1991-08-13 Pfizer Inc. 6-fluoro-1,4-dihydroquinol-4-one-3-carboxylic acid derivatives and intermediates therefor
US5104868A (en) * 1988-06-21 1992-04-14 Pfizer Inc. Tricyclic derivatives of 7-substituted-6-fluoro-1,4-dihydroquinol-4-one-3-carboxylic acids and esters
US5233091A (en) * 1988-06-21 1993-08-03 Pfizer Inc. 6-fluoro-1,4-dihydroquinol-4-one-3-carboxylic acid derivatives and intermediates therefor
EP0486687A4 (en) * 1989-07-21 1992-06-17 Iolab Corporation Quinolonecarboxylic acid derivatives
US20070275994A1 (en) * 2003-06-06 2007-11-29 Lohray Braj B Novel Antinfective Compounds

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1175836A (en) * 1977-09-20 1984-10-09 Marcel Pesson Production of 1,4-dihydroquinoline-3-carboxylic acid derivatives
DE3142854A1 (de) * 1981-10-29 1983-05-11 Bayer Ag, 5090 Leverkusen 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7-piperazino-chinolin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
SE440354B (sv) * 1981-02-19 1985-07-29 Kyorin Seiyaku Kk Kinolinkarboxylsyraderivat
US4499091A (en) * 1982-03-31 1985-02-12 Sterling Drug Inc. 1-Amino (or substituted amino)-1,4-dihydro-4-oxo-6-fluoro-7-heterylquinoline-3-carboxylic acids and their use as antibacterial agents
DE3248507A1 (de) * 1982-12-29 1984-07-05 Bayer Ag, 5090 Leverkusen Mikrobizide mittel auf chinoloncarbonsaeure basis
FR2559484B2 (fr) * 1983-07-06 1986-09-26 Provesan Sa Nouveau derive 7-(pyrrol-1-yl) de l'acide 1-ethyl-1,4-dihydro-4-oxo-(1,8-naphtyridin)-3-carboxylique, sa preparation et son application en tant que medicament
IT1221492B (it) * 1984-03-13 1990-07-06 Biochem Design Srl Acidi 7-(1-pirril)-e 7-(1-pirroli-dinil)-6-fluoro-1-etil-1,4-diidro-4-chetochinolin-3-carbossilici ad attivita' antimicrobiche,loro procedimento di preparazione e composti farmaceutici che li contengono
US4571396A (en) * 1984-04-16 1986-02-18 Warner-Lambert Company Antibacterial agents
US4636506A (en) * 1984-12-06 1987-01-13 Pfizer, Inc. 7-heterocyclic-1,4-dihydroquinolones

Also Published As

Publication number Publication date
EP0187085A1 (fr) 1986-07-09
ES8704930A1 (es) 1987-05-01
SU1426453A3 (ru) 1988-09-23
HUT40640A (en) 1987-01-28
PL146541B1 (en) 1989-02-28
CS921385A2 (en) 1987-12-17
RO93482B (ro) 1988-01-02
RO93482A (ro) 1987-12-31
CS258136B2 (en) 1988-07-15
ES550689A0 (es) 1987-05-01
PT81652B (pt) 1988-04-21
YU192385A (en) 1988-04-30
ATE56446T1 (de) 1990-09-15
PT81652A (fr) 1986-01-01
PL256757A1 (en) 1986-10-07
YU43691B (en) 1989-10-31
EP0187085B1 (fr) 1990-09-12
JPH0312064B2 (en, 2012) 1991-02-19
DE3579683D1 (de) 1990-10-18
FR2574404B1 (fr) 1987-04-24
JPS61197577A (ja) 1986-09-01
FR2574404A1 (fr) 1986-06-13
DD242042A5 (de) 1987-01-14
US4727080A (en) 1988-02-23

Similar Documents

Publication Publication Date Title
EP0799833B1 (fr) Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments
EP0885234B1 (fr) Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
US4886810A (en) Quinoline derivatives, pharmaceutical composition and method of use
FR2697524A1 (fr) Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2555584A1 (fr) Derives de l'acide fluoro-6-dihydro-1,4-oxo-4-piperazinyl substitue-7-quinoline-carboxylique-3 et procede pour leur preparation et compositions pharmaceutiques a action anti-bacteriennes a base desdits derives
HU195802B (en) Process for production of 1-cycloprophil-6-fluor-7-/pirrol-1-il/-1,4-dihydro-3-carboxi-4-oxo-quinoline and medical compositions containing them
US4552882A (en) 7-(1-Pyrrolyl) derivatives of 1-ethyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acids and 1-ethyl-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acids and their use as antimicrobial agents
FR2493852A1 (fr) Nouveaux antibiotiques, leur preparation et leur utilisation
EP0931088B1 (fr) Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
JPS6339880A (ja) 新規な１，８−橋状結合された４−キノロンカルボン酸類およびこれらを含有している薬品類
JP2777661B2 (ja) ベンゾヘテロ環化合物
US4698350A (en) 1-ethyl-6-fluoro-1,4-dihydro-7-(2,6-dimethyl-4-pyridinyl)-4-oxo-3-quinolinecarboxylic acid and antibacterial use thereof
JPH026756B2 (en, 2012)
US4016158A (en) Cephalosporin derivatives
CA2338172C (fr) Nouveaux derives de la 6-deoxy erythromycine, leur procede de preparation et leur application comme medicaments
DE3200427A1 (de) Neue organische verbindung, verfahren zu ihrer herstellung und ihre verwendung
JPH04235188A (ja) ペネム化合物の結晶、その製造方法および抗菌剤
FR2625200A1 (en) 7-(1-Azetidinyl)-1,4-dihydro-4-oxoquinoline-3-carboxylic acid derivatives, their preparation and their application as medicaments
JPS5925795B2 (ja) ピリド〔２，３−ｃ〕アクリジン−１−ヒドロキシ−２−カルボン酸及びその誘導体並びにその製法
JPWO2005073238A1 (ja) ピリドベンズオキサジン誘導体
JPS63246392A (ja) タイロシン誘導体
JPS6124572A (ja) 新規キノリンカルボン酸誘導体、その製造法およびそれを有効成分とする抗菌剤
WO1991016311A1 (en) 7-(substituted hydrazino)-4-oxoquinoline-3-carboxylic acid derivative, its salt and its ester
JPS60260514A (ja) フエニルプロピオン酸アミド誘導体を有効成分として含有する抗炎症剤
JPH0129795B2 (en, 2012)

Legal Events

Date Code Title Description
HU90 Patent valid on 900628
HMM4 Cancellation of final prot. due to non-payment of fee